GBA1 rs121908752: What Your Genotype Means
The rs121908752 variant in the GBA1 gene is a pathogenic missense mutation, also known as p.Leu483Pro or L444P. It is primarily associated with Gaucher disease when inherited in two copies and is recognized as a risk factor for Parkinson's disease in carriers.
What each genotype means
Typical GBA1 function
This genotype represents the common, non-pathogenic version of the GBA1 gene. Individuals with this profile do not carry the L444P mutation associated with Gaucher disease or increased Parkinson's risk.
This is the most common genotype found in the general population across all ancestries.
GBA1 carrier status
You carry one copy of the L444P variant (also known as p.Leu483Pro). Research indicates that carriers of this severe GBA1 variant may have an increased risk of developing Parkinson's disease compared to non-carriers, and you should discuss any neurological concerns with your clinician.
Carried by roughly 0.3% to 1% of the population, though frequency varies significantly by ancestry.
Increased Gaucher disease risk
This genotype involves two copies of the L444P variant, which is classified as a severe mutation in the GBA1 gene. This profile is strongly associated with Gaucher disease, a lysosomal storage disorder, and requires consultation with a medical geneticist or specialist for clinical evaluation.
This genotype is rare in the general population and is primarily identified in clinical settings among individuals diagnosed with Gaucher disease.
Understanding the rs121908752 Variant
The variant rs121908752, commonly referred to in scientific literature as L444P (or p.Leu483Pro), is a specific change in the DNA sequence of the GBA1 gene. This gene provides instructions for producing an enzyme called glucocerebrosidase (GCase). When a variant like rs121908752 occurs, it alters the structure of this enzyme, which can impair its ability to function correctly within the cell. This variant is classified as a missense mutation, meaning it results in the substitution of one amino acid for another in the protein chain. Because GBA1 is critical for lysosomal function—the cell's recycling center—changes in this gene can have significant downstream effects on cellular health, particularly in the nervous system.
The Role of GBA1 and Gaucher Disease
The GBA1 gene is responsible for breaking down a fatty substance called glucocerebroside. When the GCase enzyme is deficient or dysfunctional due to pathogenic variants, this substance accumulates in cells, leading to Gaucher disease. Gaucher disease is an autosomal recessive condition, meaning that an individual typically needs to inherit two copies of a pathogenic variant—one from each parent—to manifest the clinical symptoms of the disease. These symptoms can range widely in severity, from mild to severe, and may include organ enlargement, blood abnormalities, and in some forms, neurological involvement. Because this variant is well-documented in clinical genetics, it is a primary focus for researchers studying lysosomal storage disorders and the broader impact of GBA1 dysfunction.
Associations with Parkinson's Disease
Beyond its role in Gaucher disease, research has established a strong link between GBA1 variants and an increased risk for Parkinson's disease and related synucleinopathies. Even in individuals who are carriers—meaning they have only one copy of the variant and do not have Gaucher disease—there is evidence of an elevated risk for developing Parkinson's disease later in life. Studies suggest that the reduced activity of the GCase enzyme may contribute to the accumulation of alpha-synuclein, a protein that forms toxic clumps in the brains of people with Parkinson's. While the risk is statistically higher for carriers compared to the general population, it is important to note that carrying this variant does not guarantee the development of Parkinson's disease; the penetrance is incomplete and influenced by other genetic and environmental factors.
Interpreting Your Results
If you have received information about your status for rs121908752, it is essential to understand that this is a complex genetic association. Being a carrier of a GBA1 variant is a common finding in many populations, but it requires careful interpretation by a qualified healthcare professional or genetic counselor. You cannot use this information to diagnose yourself or predict your future health with certainty. If you are concerned about your risk for Parkinson's disease or Gaucher disease, or if you have a family history of these conditions, consult with a medical geneticist. They can provide context based on your specific family history and clinical presentation. Never make changes to your health management or medication based on genetic reports without first discussing them with your clinician.
How common is this variant?
The carrier frequency for GBA1 pathogenic variants varies significantly by ancestry, generally ranging from 0.003 to 0.01, though it is notably higher in the Ashkenazi Jewish population.
Frequently asked questions
Does having the L444P variant mean I will get Parkinson's disease?
No, having this variant does not mean you will definitely develop Parkinson's disease. It is considered a risk factor, meaning your statistical likelihood may be higher than someone without the variant, but many carriers never develop the condition.
What is the difference between being a carrier and having Gaucher disease?
A carrier typically has one copy of a pathogenic variant and usually does not show symptoms of the recessive condition. Gaucher disease typically occurs when an individual inherits two pathogenic copies of the GBA1 gene.
Should I get tested for GBA1 if I have a family history of Parkinson's?
If you have a family history of Parkinson's disease, you should discuss your concerns with a neurologist or a genetic counselor. They can help determine if genetic testing is appropriate for your specific situation.
Is there a cure for GBA1-related conditions?
There are treatments available for Gaucher disease, such as enzyme replacement therapy, which help manage symptoms. Research into therapies for GBA1-associated Parkinson's disease is ongoing, but there is currently no cure.
Sources & further reading
Educational information only, last refreshed 10/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908752?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GBA1
Also known as the N370S (p.Asn409Ser) mutation, this missense variant is a classic cause of Gaucher disease type 1 in homozygotes and significantly elevates Parkinson's disease risk in heterozygotes.
This variant is associated with an increased risk of developing Parkinson's disease, particularly in individuals of Ashkenazi Jewish descent.
A variant associated with the development of Gaucher disease and related neurological phenotypes.
A rare variant identified in clinical studies as a contributor to Gaucher disease pathology.
A pathogenic missense substitution (p.Asn409Ser, legacy N370S) conferring carrier status for autosomal recessive Gaucher disease type 1, highly prevalent in Ashkenazi Jewish ancestry.
A pathogenic missense variant (p.Leu483Pro, legacy L444P) in GBA1 determining carrier status for Gaucher disease type 1/2/3 and acting as an established susceptibility risk factor for Parkinson disease.